Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 07:00 ET | Source: Caribou Biosciences, Inc.

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with...
September 03, 2025 08:00 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee

PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving...
January 29, 2025 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
January 10, 2025 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
December 17, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
November 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
August 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
July 10, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
June 04, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
May 28, 2024 08:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences